Awardee OrganizationMASSACHUSETTS GENERAL HOSPITAL
Description
Abstract Text
Musculoskeletal disorders lead to chronic pain, disability and diminished quality of life. In addition, they
negatively impact work productivity and health care costs. While they affect individuals at all stages of life,
they are most prevalent in the fastest growing segment of our population, those over the age of 65, where they
have been reported to affect 3 out of 4 individuals.
The overall goal of the Center for Musculoskeletal Research (Center) is to foster interdisciplinary and
collaborative work that leads to a deeper understanding of musculoskeletal science, in a way promotes new
approaches to the diagnosis and treatment of musculoskeletal disorders. To this end, the Center will bring
together musculoskeletal scientists using diverse investigative approaches, support and expand
musculoskeletal research by those from other disciplines and foster the careers of Early Stage Investigators
(ESIs) and those from backgrounds underrepresented in STEM. Center investigators will be supported by
three Cores. The Administrative Core will offer an Enrichment Program, including Funding Initiatives,
Seminars and an annual Symposium. The Translational Imaging and Phenotyping Core, and the Cellular and
Molecular Analysis Core will offer education, assistance with experimental design, technical support and
services for musculoskeletal imaging, histology, histomorphometry, isolation of murine musculoskeletal cells,
bulk and single cell RNA sequencing of musculoskeletal cells, spatial transcriptomics of musculoskeletal
tissues and directed differentiation of ES or iPS cells into cells of the musculoskeletal lineage. In response to
feedback from Center Investigators, services have been expanded to support clinical and translational
investigators, including HRPqCT, Clinical Phenotyping of bones and joints and an annotated repository of
human tissues and bone cells. In addition, human histomorphometry services have been added.
Feedback and evaluation are solicited from the Advisory Committee, by surveys of Center scientists and
by their membership in 5 Committees charged with identifying and supporting new initiatives directed at
promoting collaborations and enhancing the impact of the research of Center investigators. Based on the
success of these initiatives, the Center has expanded to serve a community of investigators from over 40
Divisions/ Departments in 17 academic institutions in the greater Boston and New England area that use
diverse investigative approaches to address innovative hypotheses in musculoskeletal science, including
developmental biology, cell biology, genetics, biomechanics, tissue engineering, arthritis, tendon biology and
human clinical investigation. Thus, the Center will continue to enhance collaborations and support the impact
Center investigators’ research, to expand its community by supporting musculoskeletal research by ESIs and
by established investigators from other disciplines, and enhance diversity through outreach programs. The
Center is committed to sharing its innovations with the community of musculoskeletal scientists worldwide.
Public Health Relevance Statement
Musculoskeletal diseases are among the most prevalent health conditions and lead to chronic
pain, disability, psychological distress and decreased quality of life. Thus, research into the
prevention and treatment of these disorders is critically needed. The overall goal of the Center
for Musculoskeletal Research is to foster interdisciplinary and collaborative work that leads to a
deeper understanding of musculoskeletal science, in a way promotes new approaches to the
diagnosis and treatment of musculoskeletal diseases.
National Institute of Arthritis and Musculoskeletal and Skin Diseases
CFDA Code
846
DUNS Number
073130411
UEI
FLJ7DQKLL226
Project Start Date
19-June-2019
Project End Date
30-June-2029
Budget Start Date
03-July-2024
Budget End Date
30-June-2025
Project Funding Information for 2024
Total Funding
$840,161
Direct Costs
$592,392
Indirect Costs
$247,769
Year
Funding IC
FY Total Cost by IC
2024
National Institute of Arthritis and Musculoskeletal and Skin Diseases
$840,161
Year
Funding IC
FY Total Cost by IC
Sub Projects
No Sub Projects information available for 2P30AR075042-06
Publications
Publications are associated with projects, but cannot be identified with any particular year of the project or fiscal year of funding. This is due to the continuous and cumulative nature of knowledge generation across the life of a project and the sometimes long and variable publishing timeline. Similarly, for multi-component projects, publications are associated with the parent core project and not with individual sub-projects.
No Publications available for 2P30AR075042-06
Patents
No Patents information available for 2P30AR075042-06
Outcomes
The Project Outcomes shown here are displayed verbatim as submitted by the Principal Investigator (PI) for this award. Any opinions, findings, and conclusions or recommendations expressed are those of the PI and do not necessarily reflect the views of the National Institutes of Health. NIH has not endorsed the content below.
No Outcomes available for 2P30AR075042-06
Clinical Studies
No Clinical Studies information available for 2P30AR075042-06
News and More
Related News Releases
No news release information available for 2P30AR075042-06
History
No Historical information available for 2P30AR075042-06
Similar Projects
No Similar Projects information available for 2P30AR075042-06